Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 26343 | 211 | 22.3 | 52% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 917 | 10527 | EVIDENCE BASED MEDICINE//BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION//PUBLICATION BIAS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | RUN IN PERIOD | Author keyword | 3 | 60% | 1% | 3 |
| 2 | THERAPEUTIC INFORMATION | Author keyword | 3 | 60% | 1% | 3 |
| 3 | RUN IN | Author keyword | 2 | 38% | 2% | 5 |
| 4 | EFFECT MODEL | Author keyword | 2 | 36% | 2% | 5 |
| 5 | INFORMATION ON THERAPEUTICS | Author keyword | 1 | 100% | 1% | 2 |
| 6 | PERTINENT INFORMATION | Author keyword | 1 | 100% | 1% | 2 |
| 7 | THERAPY TARGET POPULATION | Author keyword | 1 | 100% | 1% | 2 |
| 8 | UNITE PHARM CLIN | Address | 1 | 100% | 1% | 2 |
| 9 | ABCDE BUNDLE | Author keyword | 1 | 50% | 0% | 1 |
| 10 | ACTUAL BENEFIT | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | RUN IN PERIOD | 3 | 60% | 1% | 3 | Search RUN+IN+PERIOD | Search RUN+IN+PERIOD |
| 2 | THERAPEUTIC INFORMATION | 3 | 60% | 1% | 3 | Search THERAPEUTIC+INFORMATION | Search THERAPEUTIC+INFORMATION |
| 3 | RUN IN | 2 | 38% | 2% | 5 | Search RUN+IN | Search RUN+IN |
| 4 | EFFECT MODEL | 2 | 36% | 2% | 5 | Search EFFECT+MODEL | Search EFFECT+MODEL |
| 5 | INFORMATION ON THERAPEUTICS | 1 | 100% | 1% | 2 | Search INFORMATION+ON+THERAPEUTICS | Search INFORMATION+ON+THERAPEUTICS |
| 6 | PERTINENT INFORMATION | 1 | 100% | 1% | 2 | Search PERTINENT+INFORMATION | Search PERTINENT+INFORMATION |
| 7 | THERAPY TARGET POPULATION | 1 | 100% | 1% | 2 | Search THERAPY+TARGET+POPULATION | Search THERAPY+TARGET+POPULATION |
| 8 | ABCDE BUNDLE | 1 | 50% | 0% | 1 | Search ABCDE+BUNDLE | Search ABCDE+BUNDLE |
| 9 | ACTUAL BENEFIT | 1 | 50% | 0% | 1 | Search ACTUAL+BENEFIT | Search ACTUAL+BENEFIT |
| 10 | BAYESIAN OUTLIER DETECTION | 1 | 50% | 0% | 1 | Search BAYESIAN+OUTLIER+DETECTION | Search BAYESIAN+OUTLIER+DETECTION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PREPUBLICATION RELEASE | 1 | 40% | 1% | 2 |
| 2 | ANEURYSM SURGERY TRIAL | 1 | 50% | 0% | 1 |
| 3 | PHYSIODIRECT TELEPHONE ASSESSMENT | 1 | 50% | 0% | 1 |
| 4 | INFLUENCE MEDICAL PRACTICE | 1 | 20% | 1% | 3 |
| 5 | CARE COORDINATION HOME TELEHEALTH | 0 | 14% | 0% | 1 |
| 6 | EFFECT MODEL | 0 | 14% | 0% | 1 |
| 7 | PLACEBO RUN IN | 0 | 14% | 0% | 1 |
| 8 | INFARCTION PATIENTS | 0 | 13% | 0% | 1 |
| 9 | EPIDEMIOLOGIC CONTEXT | 0 | 10% | 0% | 1 |
| 10 | STROKE STATISTICS 2013 UPDATE | 0 | 10% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| INFORMATION ON THERAPEUTICS - HOW TO TRANSFER THE ACTUAL STATE OF KNOWLEDGE | 1994 | 6 | 47 | 21% |
| Association of run-in periods with weight loss in obesity randomized controlled trials | 2014 | 0 | 7 | 29% |
| PRESENTATION OF THE RESULTS OF A GENERAL-REVIEW | 1993 | 0 | 12 | 42% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | UNITE PHARM CLIN | 1 | 100% | 0.9% | 2 |
| 2 | CLIN PHARMACOL EA643 | 1 | 50% | 0.5% | 1 |
| 3 | MD ANDERSON CANCER EPIDEMIOL | 1 | 50% | 0.5% | 1 |
| 4 | REG ANTICANC | 1 | 50% | 0.5% | 1 |
| 5 | EA643 | 1 | 22% | 0.9% | 2 |
| 6 | CIC 201 | 0 | 15% | 0.9% | 2 |
| 7 | AFS | 0 | 25% | 0.5% | 1 |
| 8 | PUBL HLTH BIOMETRY | 0 | 25% | 0.5% | 1 |
| 9 | PUBL HLTH SCI HLTH POLICY MANAGEMENT EVA | 0 | 20% | 0.5% | 1 |
| 10 | RTH LAENNEC MED | 0 | 20% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000100118 | ACADEMIC DETAILING//DRUG UTILIZATION REVIEW//ADVANCED PULMONARY DISEASE |
| 2 | 0.0000083095 | REGIME AMPI//SERV MED ASSURANCE MALAD//ECHELON |
| 3 | 0.0000080710 | CONSORT//OTTAWA METHODS//REPORTING QUALITY |
| 4 | 0.0000079910 | CEREBRAL ISCHEMIA PREVENTION AND CONTROL//INFORMAT METR STUDIES//GR H REP ENTAT |
| 5 | 0.0000078654 | INTERNATIONAL CLINICAL RESEARCH//ACTUAL BENEFIT//CHILD ABUSE HOMICIDE |
| 6 | 0.0000078140 | NUMERACY//RISK COMMUNICATION//RISK LITERACY |
| 7 | 0.0000069530 | COLLATERAL CORONARY FLOW//ADV MED TRAINING STATE//BETA BLOCKER |
| 8 | 0.0000069472 | MIXED TREATMENT COMPARISONS//NETWORK META ANALYSIS//RESEARCH SYNTHESIS METHODS |
| 9 | 0.0000069226 | YALE CHEM//CONSEQUENCES ANALYSIS//DATA TRANSFERABILITY |
| 10 | 0.0000068605 | BRIDGING STUDY//MULTIREGIONAL CLINICAL TRIAL//MULTIREGIONAL TRIAL |